Sep 17 2024
A new case report, published in the journal Clinical Case Reports and available online through the National Institutes of Health, suggests that psilocybin may offer a promising treatment option for patients with Complex Regional Pain Syndrome (CRPS). The study was conducted by researchers from Johns Hopkins University School of Medicine, the University of California San …
Sep 14 2024
According to a new study published in the journal Pain Management Nursing, hemp seed oil may help alleviate the pain associated with knee osteoarthritis (OA), a widespread and crippling condition, especially for the elderly. The randomized, double-blind controlled trial aimed to determine if topical hemp seed oil could provide relief comparable to standard treatments like …
Sep 13 2024
A recent study published in the Journal of Cellular and Molecular Medicine has revealed that cannabidiol (CBD) may have antiviral properties against the SARS-CoV-2 virus, which causes COVID-19. “The aim of this study was to determine the antiviral activity of cannabidiol (CBD) against SARS-CoV-2 infection”, states the study’s abstract. “CBD is the second most studied …
Sep 12 2024
A new case report published in the Journal of Palliative Medicine reveals the potential of psilocybin-assisted therapy (PAT) to provide relief for patients with terminal brain cancer facing existential distress. Conducted at McGill University, the study follows a patient with stage 4 astrocytoma who, after conventional treatments failed, found significant psychological relief through PAT—without any …
Sep 12 2024
Federal cannabis legalization could significantly reduce prices in high-cost U.S. markets, according to a new analysis published in the American Journal of Agricultural Economics. The study, conducted by an economist from North Carolina State University, found that cannabis is typically cheaper in states where it is legal. The study notes that while a super-majority of …
Sep 12 2024
A new study published in the Cochrane Database of Systematic Reviews has revealed that psychedelic-assisted therapy may help reduce anxiety, depression, and existential distress in individuals facing life-threatening diseases. Researchers from Brigham and Women’s Hospital (Boston), Dana-Farber Cancer Institute (Boston), University of Basel (Switzerland), Geneva University Hospitals (Switzerland), and the University of Freiburg (Germany) collaborated …
Sep 11 2024
A new study published in JAMA Network Open reveals that the legalization of cannabis, whether medical or recreational, is associated with significant changes in the use of prescription medications for mental health disorders. The study, which analyzed data from over 9.4 million commercially insured patients, found a notable reduction in the dispensing of benzodiazepines—medications commonly …
Sep 05 2024
A study published recently in the journal ACR Open Rheumatology reveals that a significant number of patients with rheumatic conditions in the U.S. and Canada are substituting medical marijuana for traditional medications. Conducted by researchers from the University at Buffalo, McGill University, and the University of Michigan Medical School, the study analyzed responses from 763 …
Sep 05 2024
A groundbreaking study published in the per reviewed journal Neurotherapeutics shows that a combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) may offer new hope for treating Alzheimer’s disease (AD). “A combination of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) at non-psychoactive doses was previously demonstrated to reduce cognitive decline in APP/PS1 mice, an animal model of Alzheimer’s …
Sep 05 2024
A new study published in the journal Nature Communications reveals that cannabidiol (CBD) may offer a breakthrough in treating primary mitochondrial diseases (MD), a group of untreatable disorders caused by mutations in energy-producing genes. The research specifically focuses on Leigh syndrome (LS), the most common pediatric MD, which is marked by progressive neuromuscular impairment and …
